Molecular imaging of biological processes from MicroPET in mice to PET in patients

Michael E. Phelps, Arion Chatziioannou, Simon R Cherry, Sanjiv Garabhir

Research output: Chapter in Book/Report/Conference proceedingConference contribution

3 Citations (Scopus)

Abstract

This article focuses on bringing together mice to patients with microPET to PET and molecular imaging probes and drugs for molecular diagnostics and molecular therapeutics. In the latter there is a common disease target in which near massless amounts of a molecular imaging probe is used to image the presence and function of the target and then to use the same molecule, or analogs of it, in mass amounts to modify the function of the target therapeutically. The biological world has gone molecular from the revolutionary paradigm shift from the genome, proteome and systems biology to molecular biology, molecular pharmacology, molecular therapeutics, molecular diagnostics, molecular medicine and molecular imaging. The heart of this movement is the molecular basis of instructions, communication, regulation and function of the cellular make up of the body. Classical nomenclature and descriptions of disease are giving way to molecular descriptions of disease to define the diagnostic and disease information required to select and evaluate molecular therapies. As the basis of disease and its therapeutic management shifts to the molecular basis of the biology of disease, imaging diagnostics must shift to this basis also. Many advances in various molecular and anatomical techniques are occurring to meet this challenge from research to clinical practice.

Original languageEnglish (US)
Title of host publicationProceedings - International Symposium on Biomedical Imaging
PublisherIEEE Computer Society
Pages1-9
Number of pages9
Volume2002-January
ISBN (Print)078037584X
DOIs
StatePublished - 2002
EventIEEE International Symposium on Biomedical Imaging, ISBI 2002 - Washington, United States
Duration: Jul 7 2002Jul 10 2002

Other

OtherIEEE International Symposium on Biomedical Imaging, ISBI 2002
CountryUnited States
CityWashington
Period7/7/027/10/02

Fingerprint

Biological Phenomena
Molecular imaging
Molecular Imaging
Molecular Probes
Molecular Pathology
Molecular Biology
Molecular Medicine
Molecular biology
Systems Biology
Diagnostic Imaging
Proteome
Therapeutics
Terminology
Medicine
Genes
Communication
Genome
Pharmacology
Proteins
Imaging techniques

Keywords

  • Biological processes
  • Cardiac disease
  • Cardiovascular diseases
  • Cells (biology)
  • Drugs
  • Mice
  • Molecular imaging
  • Positron emission tomography
  • Probes
  • Systems biology

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Cite this

Phelps, M. E., Chatziioannou, A., Cherry, S. R., & Garabhir, S. (2002). Molecular imaging of biological processes from MicroPET in mice to PET in patients. In Proceedings - International Symposium on Biomedical Imaging (Vol. 2002-January, pp. 1-9). [1029179] IEEE Computer Society. https://doi.org/10.1109/ISBI.2002.1029179

Molecular imaging of biological processes from MicroPET in mice to PET in patients. / Phelps, Michael E.; Chatziioannou, Arion; Cherry, Simon R; Garabhir, Sanjiv.

Proceedings - International Symposium on Biomedical Imaging. Vol. 2002-January IEEE Computer Society, 2002. p. 1-9 1029179.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Phelps, ME, Chatziioannou, A, Cherry, SR & Garabhir, S 2002, Molecular imaging of biological processes from MicroPET in mice to PET in patients. in Proceedings - International Symposium on Biomedical Imaging. vol. 2002-January, 1029179, IEEE Computer Society, pp. 1-9, IEEE International Symposium on Biomedical Imaging, ISBI 2002, Washington, United States, 7/7/02. https://doi.org/10.1109/ISBI.2002.1029179
Phelps ME, Chatziioannou A, Cherry SR, Garabhir S. Molecular imaging of biological processes from MicroPET in mice to PET in patients. In Proceedings - International Symposium on Biomedical Imaging. Vol. 2002-January. IEEE Computer Society. 2002. p. 1-9. 1029179 https://doi.org/10.1109/ISBI.2002.1029179
Phelps, Michael E. ; Chatziioannou, Arion ; Cherry, Simon R ; Garabhir, Sanjiv. / Molecular imaging of biological processes from MicroPET in mice to PET in patients. Proceedings - International Symposium on Biomedical Imaging. Vol. 2002-January IEEE Computer Society, 2002. pp. 1-9
@inproceedings{f1467f66d50e456c93c41038426e4e13,
title = "Molecular imaging of biological processes from MicroPET in mice to PET in patients",
abstract = "This article focuses on bringing together mice to patients with microPET to PET and molecular imaging probes and drugs for molecular diagnostics and molecular therapeutics. In the latter there is a common disease target in which near massless amounts of a molecular imaging probe is used to image the presence and function of the target and then to use the same molecule, or analogs of it, in mass amounts to modify the function of the target therapeutically. The biological world has gone molecular from the revolutionary paradigm shift from the genome, proteome and systems biology to molecular biology, molecular pharmacology, molecular therapeutics, molecular diagnostics, molecular medicine and molecular imaging. The heart of this movement is the molecular basis of instructions, communication, regulation and function of the cellular make up of the body. Classical nomenclature and descriptions of disease are giving way to molecular descriptions of disease to define the diagnostic and disease information required to select and evaluate molecular therapies. As the basis of disease and its therapeutic management shifts to the molecular basis of the biology of disease, imaging diagnostics must shift to this basis also. Many advances in various molecular and anatomical techniques are occurring to meet this challenge from research to clinical practice.",
keywords = "Biological processes, Cardiac disease, Cardiovascular diseases, Cells (biology), Drugs, Mice, Molecular imaging, Positron emission tomography, Probes, Systems biology",
author = "Phelps, {Michael E.} and Arion Chatziioannou and Cherry, {Simon R} and Sanjiv Garabhir",
year = "2002",
doi = "10.1109/ISBI.2002.1029179",
language = "English (US)",
isbn = "078037584X",
volume = "2002-January",
pages = "1--9",
booktitle = "Proceedings - International Symposium on Biomedical Imaging",
publisher = "IEEE Computer Society",

}

TY - GEN

T1 - Molecular imaging of biological processes from MicroPET in mice to PET in patients

AU - Phelps, Michael E.

AU - Chatziioannou, Arion

AU - Cherry, Simon R

AU - Garabhir, Sanjiv

PY - 2002

Y1 - 2002

N2 - This article focuses on bringing together mice to patients with microPET to PET and molecular imaging probes and drugs for molecular diagnostics and molecular therapeutics. In the latter there is a common disease target in which near massless amounts of a molecular imaging probe is used to image the presence and function of the target and then to use the same molecule, or analogs of it, in mass amounts to modify the function of the target therapeutically. The biological world has gone molecular from the revolutionary paradigm shift from the genome, proteome and systems biology to molecular biology, molecular pharmacology, molecular therapeutics, molecular diagnostics, molecular medicine and molecular imaging. The heart of this movement is the molecular basis of instructions, communication, regulation and function of the cellular make up of the body. Classical nomenclature and descriptions of disease are giving way to molecular descriptions of disease to define the diagnostic and disease information required to select and evaluate molecular therapies. As the basis of disease and its therapeutic management shifts to the molecular basis of the biology of disease, imaging diagnostics must shift to this basis also. Many advances in various molecular and anatomical techniques are occurring to meet this challenge from research to clinical practice.

AB - This article focuses on bringing together mice to patients with microPET to PET and molecular imaging probes and drugs for molecular diagnostics and molecular therapeutics. In the latter there is a common disease target in which near massless amounts of a molecular imaging probe is used to image the presence and function of the target and then to use the same molecule, or analogs of it, in mass amounts to modify the function of the target therapeutically. The biological world has gone molecular from the revolutionary paradigm shift from the genome, proteome and systems biology to molecular biology, molecular pharmacology, molecular therapeutics, molecular diagnostics, molecular medicine and molecular imaging. The heart of this movement is the molecular basis of instructions, communication, regulation and function of the cellular make up of the body. Classical nomenclature and descriptions of disease are giving way to molecular descriptions of disease to define the diagnostic and disease information required to select and evaluate molecular therapies. As the basis of disease and its therapeutic management shifts to the molecular basis of the biology of disease, imaging diagnostics must shift to this basis also. Many advances in various molecular and anatomical techniques are occurring to meet this challenge from research to clinical practice.

KW - Biological processes

KW - Cardiac disease

KW - Cardiovascular diseases

KW - Cells (biology)

KW - Drugs

KW - Mice

KW - Molecular imaging

KW - Positron emission tomography

KW - Probes

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=84948659306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948659306&partnerID=8YFLogxK

U2 - 10.1109/ISBI.2002.1029179

DO - 10.1109/ISBI.2002.1029179

M3 - Conference contribution

SN - 078037584X

VL - 2002-January

SP - 1

EP - 9

BT - Proceedings - International Symposium on Biomedical Imaging

PB - IEEE Computer Society

ER -